Potentiation of Procedural Motor Learning in Health and Disease
NCT ID: NCT00126087
Last Updated: 2013-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
18 participants
INTERVENTIONAL
2005-07-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Motor Inhibition in Parkinson's Disease and Focal Hand Dystonia
NCT05209516
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
NCT00306124
Neuromodulation and Language Acquisition (Project Stage Ia)
NCT00102284
Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation
NCT00853866
Data-Driven Characterization of Neuronal Markers During Deep Brain Stimulation for Patients With Parkinson's Disease
NCT03079960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* expand these exciting findings to procedural motor learning;
* explore the interaction with age, brain lesions, add-on interventions such as transcranial direct current stimulation (tDCS); and
* illuminate the underlying mechanisms.
The effect of levodopa +/- tDCS on procedural motor learning and cortical excitability will be studied in healthy volunteers and stroke patients. Then the investigator plans to delineate the underlying mechanisms of this effect by exploring N-methyl-D-asparate (NMDA) receptor-dependency of levodopa-enhanced learning and changes in activation and connectivity (using functional magnetic resonance imaging) in the respective neural networks resulting from the interaction of learning and dopaminergic neuromodulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dopamine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal neurological examination
* Mini Mental State Examination of \> 27
* Right handedness
Stroke Patients:
* Cortical or subcortical stroke with an initial severe hemiparesis Medical Research Council (MRC) scale \< 2 that has recovered to a degree that patients are able to perform the proposed task (in general \> MRC 4.5, with low spasticity, work in progress on motor learning in stroke patients)
* At least 1 year post-stroke
* Mini Mental State Examination of \> 27
* Right-handedness
Exclusion Criteria
* No antipsychotic, antidepressant drugs, and drugs affecting the dopaminergic system.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Agnes Flöel, MD
Role: PRINCIPAL_INVESTIGATOR
University of Münster, Department of Neurology, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Münster, Department of Neurology
Münster, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Floel A, Breitenstein C, Hummel F, Celnik P, Gingert C, Sawaki L, Knecht S, Cohen LG. Dopaminergic influences on formation of a motor memory. Ann Neurol. 2005 Jul;58(1):121-30. doi: 10.1002/ana.20536.
Rosser N, Heuschmann P, Wersching H, Breitenstein C, Knecht S, Floel A. Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Rehabil. 2008 Sep;89(9):1633-41. doi: 10.1016/j.apmr.2008.02.030.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Motor-Neuromod_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.